Prospects for minocycline neuroprotection

Arch Neurol. 2010 Dec;67(12):1442-8. doi: 10.1001/archneurol.2010.191. Epub 2010 Aug 9.

Abstract

Minocycline is a clinically available antibiotic and anti-inflammatory drug that also demonstrates neuroprotective properties in a variety of experimental models of neurological diseases. There have thus far been more than 300 publications on minocycline neuroprotection, including a growing number of human studies. Our objective is to critically review the biological basis and translational potential of this action of minocycline on the nervous system.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / statistics & numerical data
  • Disease Models, Animal
  • Humans
  • Minocycline / pharmacology
  • Minocycline / therapeutic use*
  • Nervous System Diseases / drug therapy*
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Signal Transduction / drug effects

Substances

  • Neuroprotective Agents
  • Minocycline